Efficacy of oral etoposide in patients with platinum and taxane-resistant intensively pretreated ovarian cancer

被引：0
|
作者：
Makhnova, Elena V. [1 ]
Gershanovich, Michael L. [1 ]
机构：
[1] NN Petrov Oncol Res Inst, St Petersburg, Russia
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：128 / 129
页数：2
相关论文
共 50 条
  • [41] Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
    Thejeswar, N.
    Goenka, L.
    Dubashi, B.
    Kayal, S.
    Jayanthi, M.
    Barathi, D.
    Ganesan, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S1510 - S1510
  • [42] Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
    Nakka, Thejeswar
    Goenka, Luxitaa
    Dubashi, Biswajit
    Kayal, Smita
    Mathaiyan, Jayanthi
    Barathi, Deepak
    Krishnamoorthy, Narendran
    Thumaty, Divya Bala
    Dahagama, Sindhu
    Ganesan, Prasanth
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [43] Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
    Thejeswar Nakka
    Luxitaa Goenka
    Biswajit Dubashi
    Smita Kayal
    Jayanthi Mathaiyan
    Deepak Barathi
    Narendran Krishnamoorthy
    Divya Bala Thumaty
    Sindhu Dahagama
    Prasanth Ganesan
    Medical Oncology, 39
  • [44] Phase II study of ortataxel in taxane-resistant breast cancer
    Beer, M.
    Lenaz, L.
    Amadori, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer
    Lee, Y.
    Hwang, J.
    Yoo, H.
    Lim, M.
    Seo, S.
    Park, S.
    Kang, S.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S21 - S22
  • [46] Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer
    Hwang, Jong Ha
    Yoo, Heon Jong
    Lim, Myong Cheol
    Seo, Sang-Soo
    Park, Sang-Yoon
    Kang, Sokbom
    ANTI-CANCER DRUGS, 2012, 23 (03) : 321 - 325
  • [47] A phase II trial of a novel taxane BAY 59-8862 in patients with metastatic taxane-resistant breast cancer
    Georgoulias, V
    Santoro, A
    Amadori, D
    Jones, A
    Pilz, K
    Lankhaar, G
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S85 - S85
  • [48] Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study
    Zhou, Huimei
    Liu, Qian
    Zhang, Depu
    Li, Qingshui
    Cao, Dongyan
    Cheng, Ninghai
    Wan, Xirun
    Zhang, Ying
    Feng, Fengzhi
    Xiang, Yang
    Yang, Jiaxin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (11) : 1761 - 1767
  • [49] Oral Etoposide for Platinum-Resistant and Recurrent Epithelial Ovarian Cancer: a Study by the Anatolian Society of Medical Oncology
    Kucukoner, Mehmet
    Isikdogan, Abdurrahman
    Yaman, Sebnem
    Gumusay, Ozge
    Unal, Olcun
    Ulas, Arife
    Elkiran, Emir T.
    Kaplan, Muhammed A.
    Ozdemir, Nuriye
    Inal, Ali
    Urakci, Zuhat
    Buyukberber, Suleyman
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3973 - 3976
  • [50] PROTRACTED ORAL ETOPOSIDE IN EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY IN PATIENTS WITH RELAPSED OR PLATINUM-RESISTANT DISEASE
    SEYMOUR, MT
    MANSI, JL
    GALLAGHER, CJ
    GORE, ME
    HARPER, PG
    EVANS, TRJ
    EDMONDS, PM
    SLEVIN, ML
    BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 191 - 195
12345